DocSym
β
Searchsearch
Search
(C76.8) Malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites
More details coming soon
526 166 in individuals diagnosis malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites confirmed
230 464 deaths with diagnosis malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites
44% mortality rate associated with the disease malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites
Diagnosis malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites is diagnosed Women are 11.09% more likely than Men
233 915
Men receive the diagnosis malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites
110 882 (47.4 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
292 251
Women receive the diagnosis malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites
119 582 (40.9 %)Died from this diagnosis.
Risk Group for the Disease malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites - Men and Women aged 60-64
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites
Absence or low individual and public risk
Malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites - what does this mean
Malignant neoplasm of other and ill-defined sites is a type of cancer that develops in an organ or tissue in an area that cannot be identified. this type of cancer is often referred to as an overlapping lesion because it is composed of multiple cells that have spread to other and ill-defined sites. this type of cancer can be difficult to diagnose and treat due to its location.
What happens during the disease - malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites
Malignant neoplasm of other and ill-defined sites is caused by an uncontrolled growth of abnormal cells in the body. this growth is usually caused by a genetic mutation that leads to the cells dividing and growing at an abnormally rapid rate. these cells can spread to other areas of the body, forming overlapping lesions. these lesions can cause a variety of symptoms, depending on the location of the neoplasm. treatment options vary depending on the size and location of the lesion, but typically involve surgery, radiation, and/or chemotherapy.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
17 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neoplasm of other and ill-defined sites: overlapping lesion of other and ill-defined sites - Prevention
The best way to prevent malignant neoplasm of other and ill-defined sites is to maintain a healthy lifestyle. this includes eating a balanced diet, exercising regularly, avoiding smoking, limiting alcohol consumption, and using sun protection. additionally, regular screenings and check-ups can help to detect any signs of cancer early, allowing for prompt and effective treatment.